Publications

• November 16, 2006 Safe Handling of Nanotechnology Nature Article Andrew Maynard
• October 10, 2006 Statement of Michael R. Taylor at FDA hearing Public Meeting on Nanotechnology Materials in FDA-Regulated Products Michael R. Taylor
• October 10, 2006 FDA and Nanotechnology: Public Perceptions Matter FDA Hearings Project Director David Rejeski’s Comments at the FDA hearings David Rejeski
• October 5, 2006 FDA-Regulated Products Containing Nanotechnology Materials Submission Update David Rejeski
• October 1, 2006 Regulating the Products of Nanotechnology: Does FDA Have the Tools it Needs? PEN 5, October 2006 Michael R. Taylor
• September 28, 2006 Comments on the UK Government’s response to the Royal Society and Royal Academy of Engineering report Nanoscience and nanotechnologies: opportunities and uncertainties The Project on Emerging Nanotechnologies has submitted comments on the United Kingdom (UK) Government’s response to the Royal Society and Royal Academy of Engineering report “Nanoscience and nanotechnologies: opportunities and uncertainties.” David Rejeski
• September 21, 2006 Testimony in front of the U.S. House of Representatives Committee on Science Research on Environmental and Safety Impacts of Nanotechnology: What are the Federal Agencies Doing? Andrew Maynard
• September 1, 2006 Nanotechnology in Agriculture and Food Production: Anticipated Applications PEN 4, September 2006 Thanks to nanotechnology, tomorrow’s food will be designed by shaping molecules and atoms. Jennifer Kuzma, Peter VerHage
• July 19, 2006 FDA-Regulated products containing nanotechnology materials Initial Project Submission to FDA hearings David Rejeski
• July 1, 2006 Nanotechnology: A Research Strategy for Addressing Risk PEN 3, July 2006 This report by Dr. Andrew Maynard proposes a comprehensive framework for systematically exploring possible risks. Andrew D. Maynard

• prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• next